Lipid Association Of India Issues New Updated Heart Disease Guidelines For Indian Patients

New Delhi: The Lipid Association of India (LAI) has updated its guidelines on heart disease in Indians, ToI reported on February 24.

The fresh guidelines include new data on cardiovascular risk assessment and lipid management, the report said.

Under the new guidelines, patients have been categorised into different risk groups, Dr Raman Puri, a cardiologist and founder chairman of LAI, told the newspaper.

The guidelines suggest that individuals with metabolic syndrome and non-alcoholic fatty liver disease (NAFLD) should aim for LDL cholesterol levels below 70 mg/dL.

Furthermore, a new category called ‘Extreme Risk Group Category C’ has been introduced for a small number of patients who continue to experience chest pain despite all available treatments.

For individuals in this category, LDL cholesterol levels should ideally range between 10-15 mg/dL, as stated by Dr Vinod M Vijan, an interventional cardiologist.

LAI has been advocating for regular lipid profile screenings from the age of 20, and from the age of two for those with a family history of high cholesterol or premature coronary heart disease in men under 55 years and women under 65 years.

In cases of adopted children or families with elevated lipoprotein (a), lipid profile screenings should commence at the age of two, or as early as possible if not feasible, according to Dr Puri.

The new guidelines also recommend including lipoprotein (a) assessment in lipid profile tests for initial screening, as it is highly prevalent among 25 percent of Indians.

Related Posts

NCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 crore

The officials identified the substance as Alprazolam manufactured illegally at the lab. HYDERABAD: In one of the largest such seizures in recent times, the Narcotics Control Bureau (NCB), Hyderabad, raided…

Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha

New Delhi: The Ministry of AYUSH has detailed its regulatory framework and ongoing initiatives to monitor heavy metal content in traditional medicines, responding to parliamentary concerns over quality and safety…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

PGIMS recalls drug amid probe into deaths

PGIMS recalls drug amid probe into deaths

NPPA list brings little relief: No price cut for 25% cancer drugs

NPPA list brings little relief: No price cut for 25% cancer drugs

Centre Mandates Minimum One-Year Shelf Life For Imported Drugs

Centre Mandates Minimum One-Year Shelf Life For Imported Drugs

For Aakash Healthcare, Community People are Apples of its Eyes

For Aakash Healthcare, Community People are Apples of its Eyes

Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA

Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA

Yashoda Medicity: Baby takes a Giant Step in just One Year

Yashoda Medicity: Baby takes a Giant Step in just One Year